Neoplastic disease of the transplanted kidney


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This article describes two cases of development of tumors 22 and 1 year after kidney transplantation. The possibility and reasonability of the need for use of tumor affected donor organs for transplantation are discussed. The methods for treating tumors of transplanted kidney are described. a brief review of the literature is presented.

Full Text

Restricted Access

References

  1. Tillou X., Doerfler A., Collonb S., Kleinclauss F., Patard J.J., Badet L., Barrou B., Audet M., Bensadoun H., Berthoux E., Bigot P., Boutin J.M., Bouzguenda Y., Chambade D., Codas R., Dantal J., Deturmeny J., Devonec M., Dugardin F., Ferrière J.M., Erauso A., Feuillu B., Gigante M., Guy L., Karam G., Lebret T., Neuzillet Y., Legendre C., Perez T., Rerolle J.P., Salomon L., Sallusto F., Sénéchal C., Terrier N., Thuret R., Verhoest G., Petit J.; “Comité de Transplantation de l’Association Française d’Urologie (CTAFU)”. De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study. Am. J. Transplant. 2012;12:3308-3315.
  2. Rouprêt M., Peraldi M.N., Thaunat O., Chrétien Y., Thiounn N., Dufour B., Kreis H., Méjean A. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation. 2004;77(1):146-148.
  3. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation. 1995;59:480-492.
  4. Xiao D., Craig J.C., Chapman J.R., Dominguez-Gil B., Tong A., Wong G. Donor cancer transmission in kidney transplantation: a systematic review. Am. J. Transplant. 2013;13:2645-2648.
  5. Gomez-Veiga F., Alcaraz-Asensio A., Burgos-Revilla J., Cózar-Olmo J. Advances in uro-oncology «OncoForum»: the best of 2013. Actas. Urol. Esp. 2014;38(8):491-498.
  6. Krishnamurthi V., Novick A.C. Nephron-sparing surgery in a renal allograft. Urology. 1997;50(1):132-134.
  7. Chambade D., Meria P., Tariel E., Vérine J., De Kerviler E., Peraldi M.N., Glotz D., Desgrandchamps F., Mongiat-Artus P. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. J. Urol. 2008;180(5):2106-2109.
  8. Tillou X., Guleryuz K., Doerfler A. Nephron sparing surgery for De Novo kidney graft tumor: results from a multicenter national study. Am. J. Transplant. 2014;14(9):2120-2125.
  9. Li J.Y., Yong T.Y., Rao M., Coates P.T. Partial nephrectomy for renal cell carcinoma in an allograft kidney with limited functional reserve. Nephrol. Dial. Transplant. Plus. 2009;2(4):312-313.
  10. Gömez-Veiga F., Alcaraz-Asensio A., Burgos-Revilla J., Cózar-Olmo J. Advances in uro-oncology «OncoForum»: the best of 2011. Actas. Urol. Esp. 2012;36(7):392-395.
  11. Gonzalez-Löpez R., Bueno-Serrano G., Vazquez-Escuderos J.J., Mayor-De Castro J., Gonzalez-Enguita C. Conservative treatment of renal cell carcinoma in kidney transplantation. Actas. Urol. Esp. 2013;37(4):242-248.
  12. Tillou X., Guleryuz K., Collon S., Doerfler A. Renal cell carcinoma in functional renal graft: Toward ablative treatments. Transplant. Rev. (Orlando). 2016;30(1):20-26.
  13. Banshodani M., Kawanishi H., Marubayashi S., Shintaku S., Moriishi M., Shimamoto F., Tsuchiya S., Dohi K., Ohdan H. De novo renal cell carcinoma in a kidney allograft 20 years after transplant. Case Rep. Transplant. 2015;20:679-682.
  14. Boix R., Sanz C., Mora M., Quer A., Beyer K., Musulen E., Gonzalez C., Bayona S., Saladié J.M., Ariza A. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin. Transplantation. 2009; 87(7):1057-1061.
  15. Tillou X., Guleryuz K., Doerfler A. Nephron sparing surgery for De Novo kidney graft tumor: results from a multicenter national study. Am. J. Transplant. 2014;14(9):2120-2125.
  16. Янковой А.Г., Прокопенко Е.И., Базаев В.В., Ватазин А.В., Казанцева И.А., Гуревич Л.Е., Уренков С.Б., Синютин А.А., Степанов В.А. Органосохраняющая хирургия опухолевого поражения трансплантированной почки. Клиническая нефрология. 2015;4:49-55.
  17. Penn I. Precautions to be taken to prevent transmission of neoplastic diseases in the grafting process. In: Organ and Tissue Transplantation in the European Union. London: Graham and Trotman, 1994. P. 33-41.
  18. Taioli E., Mattuci D.A., Palmieri S., Rizzato L., Caprio M., Costa A.N. A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia. Transplantation. 2007;83(1):13-26.
  19. Nicol D.L., Preston J.M., Wall D.R., Griffin A.D., Campbell S.B., Isbel N.M., Hawley C.M., Johnson D.W. Kidneys from patients with small renal tumours: a novel source of kidneys for transplantation. BJU Int. 2008;102(2):188-192.
  20. Lugo-Baruqui J.A., Guerra G., Chen L., Burke G.W., Gaite J.A., Ciancio G. Living donor renal transplantation with incidental renal cell carcinoma from donor allograft. Transpl. Int. 2015;28(9):1126-1130.
  21. Musquera M., Pérez M., Peri L., Esforzado N., Sebastià M.C., Paredes D., Ribal M.J., Oppenheimer F., Campistol J.M., Alcaraz A. Kidneys from donors with incidental renal tumors: should they be considered acceptable option for transplantation? Transplantation. 2013;95(9):1129-1133.
  22. Kovacs G., Akhtar M., Beckwith B.J., Bugert P., Cooper C.S., Delahunt B., Eble J.N., Fleming S., Ljungberg B., Medeiros L.J., Moch H., Reuter V.E., Ritz E., Roos G., Schmidt D., Srigley J.R., Störkel S., van den Berg E., Zbar B. The Heidelberg classification of renal cell tumours. J. Pathol. 1997;183(2):131-133.
  23. Tsui K.H., Shvarts O., Smith R.B., Figlin R.A., deKernion J.B., Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 2000;163:1090-1095.
  24. Steffens S., Janssen M., Roos F.C., Becker F., Schumacher S., Seidel C., Wegener G., Thüroff J.W., Hofmann R., Stöckle M., Siemer S., Schrader M., Hartmann A., Kuczyk M.A., Junker K., Schrader A.J. Incidence and longterm prognosis of papillary compared to clear cell renal cell carcinoma - a multicentre study. Eur. J. Cancer. 2012;48(15):2347-2352.
  25. Volpe A., Novara G.,Antonelli A., Bertini R., Billia M., Carmignani G., Cunico S. C., Longo N., Martignoni G., Minervini A., Mirone V., Simonato A., Terrone C., Zattoni F., Ficarra V. Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation. Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int. 2012;110(1):76-83.
  26. Cheville J.C., Lohse C.M., Zincke H., Weaver A.L., Blute M.L. Comparisons of outcome and prognostic features among histological subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 2003;27(5):612-624.
  27. Neuzillet Y., Lechevallier E., Andre M., Daniel L., Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J. Urol. 2004;171(5):1802-1805.
  28. Buell J.F., Hanaway M.J., Thomas M., Munda R., Alloway R.R., First M.R., Woodle E.S. Donor kidneys with small renal cell cancers: can they be transplanted? Transpl. Proc. 2005;37:581-585.
  29. Birkeland S.A., Storm H.H. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other disease in organ donors. Transplantation. 2002;74(10):1409-1413.
  30. Yin M., Bastacky S., Chandran U., Becich M.J., Dhir R. Prevalence of incindental prostate cancer in the general population: a study of healthy organ donors. J. Urol. 2008;179(3):892-895.
  31. Karam G., Kalble T., Alcaraz A., Aki F.T., Budde K., Humke U., Kleinclauss F., Nicita G., Olsburgh J.O., Süsal C. Renal Transplantation. European Association of Urology, 2014.
  32. Zucchini N., Fiorentino M., DErrico Grigioni A., Rizzato L., Venettoni S., Nanni Costa A., Grigioni W.F. Italian Transplant Research Network. Italian Transplant Research Network. The Italian multiorgam donor cancer screening protocol: 2002-2005 experience. Transplantation. 2008;85(8):57-60.
  33. Kauffman H.M., Cherikh W.S., McBride M.A., Cheng Y., Hanto D.W. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation. 2007;84(2):272-274.
  34. Buell J.F., Trofe J., Hanawey M.J., Lo A., Rosengard B., Rilo H., Alloway R., Beebe T., First M.R., Woodle E.S. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130(4):660-666.
  35. Kauffman H.M., McBride M.A., Cherikh W.S., Spain P.C., Marks W.H., Roza A.M. Transplant tumor registry: donor related malignancies. Transplantation. 2002;74:358-362.
  36. Базаев В.В., Прокопенко Е.И., Ватазин А.В., Янковой А.Г., Уренков С.Б., Казанцева И.А., Гуревич Л.Е., Виноградов А.В., Щербакова Е.О., Степанов В.А. Успешное лечение рака функционирующего почечного трансплантата. Нефрология и диализ. 2015;17(4):459-467.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies